Back to member directory Sector Biotechnology - TherapeuticsSmall molecules GAT Therapeutics GAT Therapeutics is an early stage biopharma targeting orphan fibrotic diseases. GTX-11 is a novel TGF-β pathway modulator. We believe it has the potential to become mainstay therapy for orphan fibrotic diseases. Foundation date 2019 https://www.gattx.com +34 934 47 27 34 hello@gattx.com Baldiri I Reixac, 4 Barcelona 08028 Spain
